Zealand Pharma A/S (ZEAL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zealand Pharma A/S

    NASDAQ: ZEAL · Real-Time Price · USD
    17.59
    0.00 (0.00%)
    At close: Sep 29, 2022, 10:00 PM

    Zealand Pharma A/S Balance Sheet Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Cash & Equivalents
    		 1.13B
    Short-Term Investments
    		 299.04M
    Long-Term Investments
    		 26.91M
    Other Long-Term Assets
    		 30.36M
    Receivables
    		 110.39M
    Inventory
    		 118.44M
    Other Current Assets
    		 64.63M
    Total Current Assets
    		 1.72B
    Property-Plant & Equipment
    		 221.45M
    Goodwill & Intangibles
    		 53.79M
    Total Long-Term Assets
    		 346.03M
    Total Assets
    		 2.07B
    Account Payables
    		 64.56M
    Deferred Revenue
    		 53.03M
    Short-Term Debt
    		 14.9M
    Other Current Liabilities
    		 201.83M
    Total Current Liabilities
    		 334.32M
    Long-Term Debt
    		 772.53M
    Other Long-Term Liabilities
    		 32.98M
    Total Long-Term Liabilities
    		 805.51M
    Total Liabilities
    		 1.14B
    Total Debt
    		 787.43M
    Common Stock
    		 43.63M
    Retained Earnings
    		 -3.31B
    Comprehensive Income
    		 14.15M
    Shareholders Equity
    		 927.8M
    Total Investments
    		 325.95M

    Add to Watchlist